Seniors' perceptions of prescription drug advertisements: A pilot study of the potential impact on informed decision making

Patient Education and Counseling

Volumn 85, Issue 1, 2011, Pages 79-84

  Grenard, Jerry L ^a   Uy, Visith ^b   Pagán, José A ^c   Frosch, Dominick L ^b,d  

^a CLAREMONT GRADUATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

Author keywords

Direct to consumer advertising; Informed decision making; Prescription drugs; Seniors

Indexed keywords

AMLODIPINE PLUS ATORVASTATIN; ATORVASTATIN; CLOPIDOGREL; DULOXETINE; ESZOPICLONE; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; PRESCRIPTION DRUG; TOLTERODINE; VARDENAFIL;

ADULT; AGE; AGED; ARTICLE; AWARENESS; DIRECT TO CONSUMER ADVERTISING; DRUG EFFICACY; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; EXPERIENCE; FEMALE; HUMAN; INFORMED CONSENT; INFORMED DECISION MAKING; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT EDUCATION; PERSONAL EXPERIENCE; PHYSICIAN; PILOT STUDY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; VICARIOUS EXPERIENCE;

ADVERTISING AS TOPIC; AGED; AGED, 80 AND OVER; COMPREHENSION; CONSUMER HEALTH INFORMATION; DECISION MAKING; DRUG THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; PRESCRIPTION DRUGS; UNITED STATES;

EID: 80052297397     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2010.10.008     Document Type: Article

References (29)

1. Frosch D.L., Grande D., Tarn D.M., Kravitz R.L. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 2010, 100:24-32.
2. Hoek J., Maubach N. Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines. N Z Med J 2007, 120:U2425.
3. Donohue J. A history of drug advertising: the evolving roles of consumers and consumer protection. Milbank Q 2006, 84:659-699.
4. Frosch D.L., Kaplan R.M. Shared decision making in clinical medicine: past research and future directions. Am J Prev Med 1999, 17:285-294.
5. Rimer B.K., Briss P.A., Zeller P.K., Chan E.C., Woolf S.H. Informed decision making: what is its role in cancer screening?. Cancer 2004, 101(Suppl.):1214-1228.
6. Antony P. PhRMA chief medical officer testifies on DTC advertising [29-09-05].
7. Asch S.M., Kerr E.A., Keesey J., Adams J.L., Setodji C.M., Malik S., et al. Who is at greatest risk for receiving poor-quality health care?. N Engl J Med 2006, 354:1147-1156.
8. Lipsky M.S., Taylor C.A. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract 1997, 45:495-499.
9. Murray E., Lo B., Pollack L., Donelan K., Lee K. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract 2003, 16:513-524.
10. Murray E., Lo B., Pollack L., Donelan K., Lee K. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. J Am Board Fam Pract 2004, 17:6-18.
11. Weissman J.S., Blumenthal D., Silk A.J., Zapert K., Newman M., Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (Millwood) 2003, Suppl Web Exclusives: W3-95.
12. Weissman J.S., Blumenthal D., Silk A.J., Newman M., Zapert K., Leitman R., et al. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood) 2004, Suppl Web Exclusives: W4-33.
13. Frosch D.L., Krueger P.M., Hornik R.C., Cronholm P.F., Barg F.K. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med 2007, 5:6-13.
14. Macias W., Pashupati K., Lewis L.S. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Health Commun 2007, 22:241-252.
15. Schwartz L.M., Woloshin S., Welch H.G. The drug facts box: providing consumers with simple tabular data on drug benefit and harm. Med Decis Making 2007, 27:655-662.
16. Woloshin S., Schwartz L.M., Welch H.G. The value of benefit data in direct-to-consumer drug ads. Health Aff (Millwood) 2004, Suppl Web Exclusives: W4-45.
17. Brownfield E.D., Bernhardt J.M., Phan J.L., Williams M.V., Parker R.M. Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement. J Health Commun 2004, 9:491-497.
18. Corbin J.M., Strauss A.L. Basics of qualitative research: techniques and procedures for developing grounded theory 2008, Sage, Los Angeles. 3rd ed.
19. Waxman H.A. A history of adverse drug experiences: congress had ample evidence to support restrictions on the promotion of prescription drugs. Food Drug Law J 2003, 58:299-312.
20. Vladeck D.C. The difficult case of direct-to-consumer advertising. Loyola Los Angeles Law Rev 2007, 41:259-296.
21. Mintzes B., Barer M.L., Kravitz R.L., Bassett K., Lexchin J., Kazanjian A., et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ 2003, 169:405-412.
22. Datti B., Carter M.W. The effect of direct-to-consumer advertising on prescription drug use by older adults. Drugs Aging 2006, 23:71-81.
23. Rice T., Hanoch Y., Cummings J. What factors influence seniors' desire for choice among health insurance options? Survey results on the Medicare prescription drug benefit. Health Econ Policy Law 2009, 1-21.
24. Hornik R. Public health communication: making sense of contradictory evidence. Public health communication: evidence for behavior change 2002, 1-19. Lawrence Erlbaum Associates, Manwah, NJ. R.C. Hornik (Ed.).
25. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004, 160:421-429.
26. Davis J.J. Consumers' preferences for the communication of risk information in drug advertising. Health Aff (Millwood) 2007, 26:863-870.
27. Zachry W.M., Dalen J.E., Jackson T.R. Clinicians' responses to direct-to-consumer advertising of prescription medications. Arch Intern Med 2003, 163:1808-1812.
28. Richards T. Purely medicinal?. Brit Med J 2008, 336:693.
29. Tarn D.M., Heritage J., Paterniti D.A., Hays R.D., Kravitz R.L., Wenger N.S. Physician communication when prescribing new medications. Arch Intern Med 2006, 166:1855-1862.